VNIM
EBS icon

Vaughan Nelson Investment Management’s Emergent Biosolutions EBS Stock Holding History

Vaughan Nelson Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-342,494
Closed -$14.9M – 213
2021
Q4 		$14.9M Buy
342,494
+5,814
+2% +$263K 0.15% 135
2021
Q3 		$16.9M Sell
336,680
-6,375
-2% -$386K 0.17% 136
2021
Q2 		$21.6M Sell
343,055
-197,565
-37% -$12.7M 0.22% 122
2021
Q1 		$50.2M Sell
540,620
-117,146
-18% -$12M 0.54% 67
2020
Q4 		$58.9M Buy
657,766
+388,709
+144% +$35.7M 0.69% 47
2020
Q3 		$27.8M Buy
269,057
+73,161
+37% +$7.89M 0.39% 90
2020
Q2 		$15.5M Sell
195,896
-64,059
-25% -$4.77M 0.22% 133
2020
Q1 		$15M Sell
259,955
-118,461
-31% -$6.83M 0.26% 120
2019
Q4 		$20.4M Sell
378,416
-299,212
-44% -$16.2M 0.25% 124
2019
Q3 		$35.4M Buy
677,628
+106,219
+19% +$4.95M 0.47% 83
2019
Q2 		$27.6M Buy
571,409
+44,009
+8% +$2.11M 0.37% 98
2019
Q1 		$26.6M Buy
+527,400
New +$31.1M 0.36% 108

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vaughan Nelson Investment Management's EBS Position: Q1 2022 in Review

Vaughan Nelson Investment Management sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 342,494 shares — an estimated $14.9M sold.

Vaughan Nelson Investment Management first reported a position in EBS in Q1 2019 and held it in 12 quarters. The position peaked at $58.9M in Q4 2020. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Vaughan Nelson Investment Management reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 342,494 Emergent Biosolutions shares in Q1 2022, an estimated $14.9M.
  • Vaughan Nelson Investment Management first reported a position in Emergent Biosolutions in Q1 2019 and held it in 12 quarters.
  • Vaughan Nelson Investment Management's Emergent Biosolutions position peaked at $58.9M in Q4 2020.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Vaughan Nelson Investment Management's 13F filing for Q1 2022, filed 4 May 2022.